Clinical Trials in Portland

Showing 6141-6160 of 10,048 trials

Measuring Preferences for Childbirth After Cesarean

NCT00267735

The objective of this proposed 18-month exploratory research study is to help pregnant women weigh risks and benefits in a childbirth decision using the Preferences-Assessment Computer Module. Our hypothesis is that, after using this computer module, women will be more aware of the potential risks and benefits of VBAC and of elective repeat cesarean and will have greater clarity about their preferences related to these risks and benefits.

Pregnancy

Oregon Health and Science University131 participantsStarted Jan 2006

Portland, Oregon, United States

COMPLETED< 1 mile

Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion

NCT04071392

The overarching goal of this study is to find an alternative method to hysterosalpingogram (HSG) to confirm bilateral tubal occlusion after permanent contraception.

Sterilization, FemaleFallopian Tube Occlusion

Oregon Health and Science University24 participantsStarted Sep 2016

Portland, Oregon, United States

COMPLETEDNA< 1 mile

Post Market Surveillance Study of the Wingspan Stent System

NCT02034058

The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.

Intracranial Atherosclerosis

Stryker Neurovascular152 participantsStarted Dec 2013

Birmingham, Alabama, United States • Castro Valley, California, United States • Los Angeles, California, United States +23 more locations

Measuring Preferences for Childbirth After Cesarean

Development of an Intrauterine Pressure Threshold to Confirm Tubal Occlusion

Post Market Surveillance Study of the Wingspan Stent System

Find Trials by Condition in Portland

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

ImageReady(TM) MR Conditional Pacing System Clinical Study

HW006 LATERAL Thoracotomy

Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC

A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer

Trial of Romidepsin and Bortezomib for Multiple Myeloma

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

A Canadian Study of the Effectiveness of Tresiba® (Insulin Degludec) After Switching Basal Insulin in a Population With Type 1 or Type 2 Diabetes Mellitus

A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects

A Clinical Trial of IntensiVE Dialysis

EPVent 2- A Phase II Study of Mechanical Ventilation Directed by Transpulmonary Pressures

International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema

Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer